Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The plasma and interstitial colloid osmotic environment, primarily defined by colloid osmotic pressure (COP) or oncotic pressure, is the osmotic force exerted by proteins (mainly albumin) that holds water within the vascular compartment (StatPearls, NBK537071). This environment is a critical component of the Starling equation, which describes the movement of fluid between the capillary and the interstitium based on the balance of hydrostatic and oncotic pressures (Guyton and Hall, Textbook of Medical Physiology). In healthy individuals, the plasma COP is significantly higher than the interstitial COP, preventing excessive fluid filtration into tissues. Pathological states such as liver cirrhosis, nephrotic syndrome, or malnutrition can lead to hypoalbuminemia, which reduces plasma oncotic pressure and results in systemic edema (NIH, PubMed ID: 23440184). Pharmacological management involves the use of colloid fluids, such as human albumin or synthetic starches, to restore this osmotic gradient and expand intravascular volume during shock or surgery. However, the use of synthetic colloids like hydroxyethyl starch has been associated with increased risks of acute kidney injury and mortality in critically ill patients (Cochrane Database Syst Rev, CD000567). Monitoring serum albumin and total protein levels serves as a proxy for assessing the stability of this osmotic environment in clinical settings. Overall, maintaining the balance between plasma and interstitial oncotic pressure is vital for hemodynamic stability and tissue perfusion.
Restoration of intravascular oncotic pressure to promote fluid shift from the interstitial space into the vasculature and maintain circulatory volume (StatPearls, NBK537071).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma and interstitial colloid osmotic pressure (COP) (COP).